Advances in Oral Systemic Treatments for Management of Atopic Dermatitis : Episode 5

Utilizing Long-Term Atopic Dermatitis Data in Clinical Practice

September 23, 2024

By Raj Chovatiya, MD, PhD
George Han, MD, PhD

Opinion

Video

Medical experts discuss long-term data for other systemic agents in atopic dermatitis and how this information informs their treatment decisions.

EP: 1.JAK Inhibitors and Pathophysiology of Atopic Dermatitis

EP: 2.Oral JAK inhibitors and Their Use for Treatment of Atopic Dermatitis

EP: 3.Oral JAK Inhibitor Use in Atopic Dermatitis: Screening and Monitoring Patients

EP: 4.Long-term Safety Data for JAK Inhibitors in Atopic Dermatitis

EP: 5.Utilizing Long-Term Atopic Dermatitis Data in Clinical Practice

EP: 6.Data on Early Itch Relief with JAK Inhibitors in Atopic Dermatitis

Video content above is prompted by the following:

Please share long-term data with other systemic agents in atopic dermatitis and how you use these data to make treatment decisions

Recent Videos

Updates on Benzoyl Peroxide Use for Acne, with James Del Rosso, DO

Nancy Reau, MD | Credit: Rush University

Tom C. Nguyen, MD: Evolving Roles of TAVR, SAVR in Aortic Valve Disease | Image Credit: Baptist Health

3 KOLs are featured in this series.

Atypical Clinical Presentations of Blistering Disease, with Donna Culton, MD, PhD

How to Address Blistering Diseases, with Donna Culton, MD, PhD

Matthew Zirwas, MD: Discussing Upadacitinib, Other JAK Inhibitors for Atopic Dermatitis

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.